Contents
to High-Density Lipoprotein, Dyslipidemia, and Coronary Heart Disease.- Regulation of ApoA-I Gene Expression and Prospects to Increase Plasma ApoA-I and HDL Levels.- High Density Lipoprotein Particles.- The Kinetics and Remodeling of HDL Particles: Lessons from Inborn Errors of Lipid Metabolism.- HDL Structure, Function, and Antiinflammatory Properties.- Human Apolipoprotein A-I Deficiency.- Human Apolipoprotein A-I Mutants.- ATP Binding Cassette A1 Transporter Function and Tangier Disease.- The Role ABCG1 in Cellular Cholesterol Efflux: Relevance to Atherosclerosis and Endothelial Function.- In Vitro Studies and Mass Flux of Cholesterol Between Serum and Macrophages.- Genetic LCAT Deficiency: Molecular Diagnosis, Plasma Lipids, and Atherosclerosis.- Human Cholesteryl Ester Transfer Protein in Human HDL Metabolism.- The HDL Receptor SR-BI.- Genetic Loci Influencing Plasma High Density Lipoprotein Cholesterol Concentrations in Humans.- Nutritional and Lifestyle Factors and High-Density Lipoprotein Metabolism.- Effects of Ethanol Intake on High Density Lipoprotein Metabolism in Humans.- Effects of Estrogen on HDL Metabolism.- Effects of Niacin on HDL Metabolism.- Effects of Statins on HDL Metabolism.- Therapeutic Regulation of High-Density Lipoprotein Transport in the Metabolic Syndrome.- Effects of Cholesterol Ester Transfer Protein Inhibition on HDL Metabolism.- HDL Infusion Therapy.- High Density Lipoproteins, Dyslipidemia, and Heart Disease: Past, Present, and Future.
